| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
The FASEB Journal, Vol 10, 1129-1136, Copyright © 1996 by The Federation of American Societies for Experimental Biology
REVIEWS |
M Aschner
Department of Physiology and Pharmacology, Bowman Gray School of Medicine, Winston-Salem, North Carolina, USA.
Metallothioneins (MTs) are ubiquitous low molecular weight proteins characterized by their abundant content of cysteines. Two MT isoforms, MT-I and MT-II, are expressed coordinately in all mammalian tissues. In the CNS, MT-I and MT-II are conspicuously absent from neuronal populations, yet abundant in fibrous and protoplasmic astrocytes. A newly identified brain-specific MT gene, MT-III, is predominantly expressed in zinc-containing neurons of the hippocampus and absent from glial elements. MTs have been implicated as regulator molecules in gene expression, homeostatic control of cellular metabolism of metals, and cellular adaptation to stress. MTs store and release essential metals, such as zinc and copper, maintaining the low intracellular concentration of free essential metals. Thus, MTs fulfill a regulatory capacity and influence transcription, replication, protein synthesis, metabolism, as well as other zinc-dependent biological processes. Because MT-III is particularly abundant in zinc-containing neurons of the hippocampus, it is likely to play an important role in neuromodulation by zinc-containing neurons and to act as a sink for free zinc. It may also play an etiologic role in various pathophysiological conditions associated with increased extracellular zinc. Studies demonstrating that MT-III prevents neuronal sprouting in vitro, appears to be down-regulated in Alzheimer's disease, and that MT- III "knockout" mice appear highly sensitive to kainateinduced seizures have focused growing attention on the etiologic role of MT-III in neurodegeneration.-Aschner, M. The functional significance of brain metallothioneins.
This article has been cited by other articles:
|
|
 |
|
  J. P. Wu, B. Y. Ma, H. W. Ren, L. P. Zhang, Y. Xiang, and M. A. Brown Characterization of metallothioneins (MT-I and MT-II) in the yak J Anim Sci, June 1, 2007; 85(6): 1357 - 1362. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Hidalgo, M. Penkowa, C. Espejo, E. M. Martinez-Caceres, J. Carrasco, A. Quintana, A. Molinero, S. Florit, M. Giralt, and A. Ortega-Aznar Expression of Metallothionein-I, -II, and -III in Alzheimer Disease and Animal Models of Neuroinflammation. Experimental Biology and Medicine, October 1, 2006; 231(9): 1450 - 1458. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Aschner, T. Syversen, D. O. Souza, and J. B.T. Rocha Metallothioneins: mercury species-specific induction and their potential role in attenuating neurotoxicity. Experimental Biology and Medicine, October 1, 2006; 231(9): 1468 - 1473. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. W. Lee, J. K Andersen, and D. Kaur Iron dysregulation and neurodegeneration: the molecular connection. Mol. Interv., April 1, 2006; 6(2): 89 - 97. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Penkowa, P. Keller, C. Keller, J. Hidalgo, M. Giralt, and B. K. Pedersen Exercise-induced metallothionein expression in human skeletal muscle fibres Exp Physiol, July 1, 2005; 90(4): 477 - 486. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Xie, L. Tong, U. D. McCann, J. Yuan, K. G. Becker, A. O. Mechan, C. Cheadle, D. M. Donovan, and G. A. Ricaurte Identification and Characterization of Metallothionein-1 and -2 Gene Expression in the Context of ({+/-})3,4-Methylenedioxymethamphetamine-Induced Toxicity to Brain Dopaminergic Neurons J. Neurosci., August 11, 2004; 24(32): 7043 - 7050. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. J. Kress, K. E. Dineley, and I. J. Reynolds The Relationship between Intracellular Free Iron and Cell Injury in Cultured Neurons, Astrocytes, and Oligodendrocytes J. Neurosci., July 15, 2002; 22(14): 5848 - 5855. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. A. Tanner, A. Abowath, and A. D. Miller Isothermal Titration Calorimetry Reveals a Zinc Ion as an Atomic Switch in the Diadenosine Polyphosphates J. Biol. Chem., January 25, 2002; 277(5): 3073 - 3078. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Musso, S. Deaglio, L. Franco, L. Calosso, R. Badolato, G. Garbarino, U. Dianzani, and F. Malavasi CD38 expression and functional activities are up-regulated by IFN-{gamma} on human monocytes and monocytic cell lines J. Leukoc. Biol., April 1, 2001; 69(4): 605 - 612. [Abstract] [Full Text]
|
|
|
|
 |
|
 A. G. Brunello, J. Weissenberger, A. Kappeler, C. Vallan, M. Peters, S. Rose-John, and J. Weis Astrocytic Alterations in Interleukin-6/Soluble Interleukin-6 Receptor {alpha} Double-Transgenic Mice Am. J. Pathol., November 1, 2000; 157(5): 1485 - 1493. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. J. Kang The Antioxidant Function of Metallothionein in the Heart Experimental Biology and Medicine, December 1, 1999; 222(3): 263 - 273. [Abstract] [Full Text]
|
|
|
|
|
|
A. R. White, G. Multhaup, F. Maher, S. Bellingham, J. Camakaris, H. Zheng, A. I. Bush, K. Beyreuther, C. L. Masters, and R. Cappai The Alzheimer's Disease Amyloid Precursor Protein Modulates Copper-Induced Toxicity and Oxidative Stress in Primary Neuronal Cultures J. Neurosci., November 1, 1999; 19(21): 9170 - 9179. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K.-B. Oh, T. Watanabe, and H. Matsuoka A novel copper-binding protein with characteristics of a metallothionein from a clinical isolate of Candida albicans Microbiology, September 1, 1999; 145(9): 2423 - 2429. [Abstract] [Full Text]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
